The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination.

Hastert, Florian D; Hein, Sascha; von Rhein, Christine; Benz, Nuka Ivalu; Husria, Younes; Oberle, Doris; Maier, Thorsten J; Hildt, Eberhard; Schnierle, Barbara S

Hastert, Florian D; Hein, Sascha; von Rhein, Christine; Benz, Nuka Ivalu; Husria, Younes; Oberle, Doris; Maier, Thorsten J; Hildt, Eberhard; Schnierle, Barbara S.

Hastert FD; Department of Virology, Section AIDS and Newly Emerging Pathogens, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Hein S; Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
von Rhein C; Department of Virology, Section AIDS and Newly Emerging Pathogens, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Benz NI; Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Husria Y; Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Oberle D; Division of Pharmacovigilance, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Maier TJ; Division of Pharmacovigilance, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Hildt E; Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Schnierle BS; Department of Virology, Section AIDS and Newly Emerging Pathogens, Paul-Ehrlich-Institut, 63225 Langen, Germany.